Autologous haematopoietic stem cell transplantation (AHSCT) is a multistep procedure that
enables destruction of the immune system and its reconstitution from haematopoietic stem …

Multiple sclerosis is one of the most common causes of chronic neurological disability
beginning in early to middle adult life. Multiple sclerosis is idiopathic in nature, yet …

Objective: To summarize the evidence on immunoablative therapy followed by autologous
hematopoietic stem cell transplantation (aHSCT) to manage severe and treatment-refractory …

Introduction In 1995, the use of autologous hematopoietic stem-cell transplantation
(AHSCT), which was previously used to treat hematological tumors, was introduced for …

Multiple sclerosis (MS) is an inflammatory disorder of the central nervous system where
evidence implicates an aberrant adaptive immune response in the accrual of neurological …

Reports from more than 600 hematopoietic stem cell transplants (HSCT) have appeared in
the medical literature for the last 1 and one-half decades. The patient's own stem cells are …

High-dose immunosuppressive therapy (HDIT) with autologous hematopoietic stem cell
transplantation (AHSCT) is a promising approach to treatment of multiple sclerosis (MS) …

Neurodegenerative diseases are caused by a loss of neurons within the peripheral or
central nervous system. Inadequate repairability in the central nervous system and failure of …

High-dose immunosuppressive therapy with autologous hematopoietic stem cell
transplantation (AHSCT) is a new and promising approach to multiple sclerosis (MS) …

Abstract Purpose of Review We summarise the current development of autologous
haematopoietic stem cell transplantation (AHSCT) in treating multiple sclerosis (MS) and …